Discover
Univadis Practice Changers
Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD
Update: 2019-09-16
Share
Description
A recent meta-analysis shows a superior risk-benefit profile for NOACs over vitamin K antagonists in patients with Afib and early-stage CKD.
Comments
In Channel



